SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-019139
Filing Date
2019-05-14
Accepted
2019-05-14 16:11:37
Documents
62
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alt-10q_20190331.htm 10-Q 1208872
2 EX-31.1 alt-ex311_9.htm EX-31.1 18170
3 EX-31.2 alt-ex312_8.htm EX-31.2 17910
4 EX-32.1 alt-ex321_6.htm EX-32.1 6187
5 EX-32.2 alt-ex322_7.htm EX-32.2 6161
  Complete submission text file 0001564590-19-019139.txt   4554714

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alt-20190331.xml EX-101.INS 818808
7 XBRL TAXONOMY EXTENSION SCHEMA alt-20190331.xsd EX-101.SCH 43698
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20190331_cal.xml EX-101.CAL 54737
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20190331_def.xml EX-101.DEF 139720
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20190331_lab.xml EX-101.LAB 350117
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20190331_pre.xml EX-101.PRE 254650
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 19822819
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences